Urinary metabolites associate with the rate of kidney function decline in patients with autosomal dominant polycystic kidney disease.

by Shosha E I Dekker, Aswin Verhoeven, Darius Soonawala, Dorien J M Peters, Johan W de Fijter, Oleg A Mayboroda, DIPAK Consortium
Published 2020-01-01

Association of plasma somatostatin with disease severity and progression in patients with autosomal dominant polycystic kidney disease

by A. Lianne Messchendorp, Edwin M. Spithoven, Niek F. Casteleijn, Wendy A. Dam, Jacob van den Born, Wouter F. Tonnis, Carlo A. J. M. Gaillard, Esther Meijer, on behalf of the DIPAK Consortium
Published 2018-12-01